Frequently Asked Questions:
The increasing adoption of biohacking products is expected to increase the market’s growth. The increasing demand for Biohacking is projected to rise as a result.
The global Biohacking market is anticipated to grow at a substantial CAGR of 19.10% in the upcoming years. The global Biohacking market was estimated to be worth USD 15578.5 million in 2021 and was expected to be worth USD 44462.73 million by 2028.
The North American region dominated the Biohacking market in 2021 with the highest market share.
Some major players in the market are Apple Inc.; The ODIN; Thync Global Inc.; Fitbit, Inc.; Moodmetric; HVMN, Inc.; Muse (Interaxon Inc.); Thriveport, LLC; TrackMyStack; OsteoStrong.
In 2021, the hospitals and clinic segment captured the highest market share in the end-user outlook segments due to the rising prevalence of chronic diseases.